Abstract
Streptococus pneumoniae represents an interesting model to discuss the relative impact of broad versus narrow spectrum antibacterials as potential selectors for resistance. Indeed, this pathogen is responsible for potentially severe infections in the community, and has a great capacity for acquisition of resistance to antibacterial agents. It has been the focus of many studies to elucidate some unique aspects of molecular biology, including the adaptive mechanisms responsible for emergence and spread of multiresistance.
In the past, the use of narrow spectrum agents was recommended in order to try to reduce the risk of selection of resistance. This concept is nowadays somewhat obsolete for several reasons. S. pneumoniae is able to acquire resistance to antibacterials belonging to different families of drugs through different molecular mechanisms. Thus, selection of multiresistant pneumococci can result from exposure to very different agents, including narrow spectrum as well as broad spectrum agents. In vitro studies have shown a different potential for selection of resistance among the β-lactam agents. Furthermore, several studies have more or less directly established a close relationship between the level of antibacterial use and the rate of selection of resistance. In addition to the overall amount of antibacterials prescribed in the community, several other factors have been shown to influence the rate of selection of resistance, including the use of doses that are too low, the length of therapy and the duration of bacterial exposure to long-acting agents compared to drugs with short half-lives.
Therefore, there are three main ways to control selection and spread of resistant strains: by (i) reducing the amount of antibacterials used; (ii) using optimal dosages (avoiding underdosing) and treatments of short duration; and (iii) reducing the risk of transmission among young children attending daycare centres or kindergartens. In order to help physicians reduce the number of unnecessary prescriptions, it is important to develop rapid tests to recognise the bacterial origin of a febrile illness and even more important to detect resistance to antibacterials. However, apart from rapid diagnostic tests for streptococcal pharyngitis, those tests are not currently available.
As a consequence, currently, the debate around narrow versus broad spectrum antibacterials remains a false debate. Physicians should use broad spectrum agents in many instances of upper or lower respiratory tract infection, taking into consideration the probable pathogens and the risk of (multi)resistance to antibacterials. Once rapid diagnostic are available in community practice, allowing a precise diagnosis of the offending agent and its susceptibility profile, physicians will be able to add to their current criteria the selective potential for resistance of the antibacterials that appear to be active in vitro.
Similar content being viewed by others
References
Austrian RS. Pneumococcus and the Brooklyn connection. Am J Med 1999; 107(1A): 2S–6S
Tomasz A. New faces of an old pathogen: emergence and spread of multidrug-resistant streptococcus pneumoniae. Am J Med 1999; 107(1A): 55S–62S
Turner PJ, Edwards JR. A compilation of studies assessing the in vitro activity of meropenem and comparators in 84 laboratories throughout Europe. Clin Microbiol Infect 1997; (4): S32-50
Chen DK, McGeer A, de Azavedo JC, et al. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. N Engl J Med 1999; 341: 233–9
Linares J, de la Campa A, Pallares R. Fluoroquinolone resistance in Streptococcus pneumoniae. N Engl J Med 1999; 341: 1546–7
Austin DJ, Kristinsson KG, Anderson RM. The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proc Natl Acad Sci U S A 1999: 96(3); 1152–1156
Davies T, Dewasse BE, Jacobs MR, et al. In vitro development of resistance to telithromycin (HMR 3647), four macrolides, clindamycin and pristinamycin in Streptococcus pneumoniae. Antimicrob Agents Chemother 2000; 44(2): 414–7
Pankuch GA, Jueneman SA, Davies TD, et al. In vitro selection of resistance to four β-lactams and azithromycin in Streptococcus pneumoniae. Antimicrob Agents Chemother 1998; 42(11): 2914–8
Guillemot D, Carbon C, Balkau B, et al. Low dosage and long treatment duration of β-lactam. Risk factors for carriage of penicillin-resistant Streptococcus pneumoniae. JAMA 1998; 279(5): 365–70
Baquero F, Negri MC, Morosini MI, et al. The antibiotic selective process: concentration-specific amplification of low-level resistant populations. Ciba Found Symp 1997; 207: 93–105
Arason VA, Kristinsson KG, Sigurdsson JA, et al. Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children?. Cross sectional prevalence study. BMJ 1996; 313: 387–91
Radetsky M, Istre GR, Johansen TL, et al. Multiply resistant pneumococcus causing meningitis: its epidemiology within a day care center. Lancet 1981; II(8250): 771–3
Pallares R. Gudiol F, Linares J, et al. Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci. N Engl J Med 1987; 317: 18–22
Reichler MR, Allphin AA, Breiman RF, et al. The spread of multiply resistant Streptococcus pneumoniae at a day care center in Ohio. J Infect Dis 1992; 166: 1346–53
Block SL, Harrison CJ, Hedrick JA, et al. Penicillin-resistant Streptococcus pneumoniae in acute otitis media: risk factors, susceptibility patterns and antimicrobial management. Pediatr Infect Dis J 1995; 14: 751–9
Duchin JS, Breiman RF, Diamond A, et al. High prevalence of multi-drug-resistant Streptococcus pneumoniae among children in a rural Kentucky community. Pediatr Infect Dis J 1995; 19: 745–50
Bćdos JP, Chevret S, Chastang C, et al. Epidemiological features of and risk factors for infection by Streptococcus pneumoniae strains with diminished susceptibility to penicillin. Clin Infect Dis 1996; 22: 63–72
Brook I, Gober AE. Prophylaxis with amoxicillin or sulfisoxazole for otitis media: Effect on the recovery of penicillin-resistant bacteria from children. Clin Infect Dis 1996; 22: 143–5
Fairchok MP, Ashton WS, Fischer GW. Carriage of penicillin-resistant pneumococci in a military population in Washington DC: Risk factors and correlation with clinical isolates. Clin Infect Dis 1996; 22: 966–72
Meynard JL, Barbut F, Blum L, et al. Risk factors for isolation of Streptococcus pneumoniae with decreased susceptibility to penicillin G from patients infected with human immunodeficiency virus. Clin Infect Dis 1996; 22: 437–40
Melander E, Mölstad K, Persson HB, et al. Previous antibiotic consumption and other risk factors for carriage of penicillin-resistant Streptococcus pneumoniae in children. Eur J Clin Microbiol Infect Dis 1998; 17: 834–8
Yagupsky P, Porat N, Fraser D, et al. Acquisition, carriage and transmission of pneumococci with decreased antibiotic susceptibility in young children attending a day care facility in southern Israel. J Infect Dis 1998; 177: 1003–12
Craig AS, Erwin P, Scaffner W, et al. Carriage of multidrug-resistant Streptococcus pneumoniae and impact of chemopro-phylaxis during an outbreak of meningitis at a day care center. Clin Infect Dis 1999; 29: 1254–64
Kellner JD, Ford-Jones EL, Members of the Toronto Child Care Study Group. Streptococcus pneumoniae carriage in children attending 59 child care centers. Arch Pediatr Adolesc Med 1999; 153:495–502
McGowan JEG. Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis 1983;5: 1033–9
Ekdahl K, Ahlinder I, Hansson HB, et al. Duration of nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae: Experiences from the South Swedish Pneumococcal Intervention Project. Clin Infect Dis 1997; 25: 1113–7
Austin DJ, Kristinsson KG, Anderson RM. The relationship between the volume of antimicrobial consumption in human community and the frequency of resistance. Proc Natl Acad Sci U S A 1999;96(3): 1152–6
Isturiz R, Carbon C. Antibiotic use in developing countries. Infect Control Hosp Epidemiol 2000; 21(6): 394–7
Baquero F, Martinez-Beltran J, Loza E. A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe. J Antimicrob Chemother 1991; 28 Suppl. C: 31–8
Pradier C, Dunais B, Carsenti-Etesse H, et al. Eur J Clin Microbiol Infect Dis 1997; 16(9): 644–7
Baquero F. Evolving resistance patterns of Streptococcus pneumoniae: A link with long acting macrolide consumption? J Chemother 1999; 11 Suppl. 1: 35–43
Vilhelmsson SE, Tomasz A, Kristinsson KG. Molecular evolution in a multidrug-resistant lineage of Streptococcus pneumoniae: emergence of strains belonging to serotype 6B Icelandic clone that lost antibiotic resistance traits. J Clin Microbiol 2000; 38(4): 1375–81
Seppälä H, Klaukka T, Vuopio Varkila J, et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in Group A streptococci. N Engl J Med 1997; 337(7): 441–6
Kristinsson KG, Hjalmarsdottir MA, Gudnason T. Continued decline in the incidence of penicillin non-susceptible pneumococci in Iceland [abstract no. C022]. 38th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). San Diego: American Society of Microbiology, 1998
Garcia-Bustos J, Tomasz A. A biological price of antibiotic resistance: major changes in the peptidoglycan structure of penicillin resistant pneumococci. Proc Natl Acad Sci U S A 1990; 87: 5414–9
Azoulay-Dupuis E, Rieux V, Muffat-Joly J, et al. Relationships between capsular type, penicillin susceptibility, and mouse virulence of human Streptococcus pneumoniae isolates in mice. Antimicrob Agents Chemother 2000; 44(6): 1575–7
Isturiz R, Azoulay-Dupuis E, Mohler J, et al. The cost of resistance: can penicillin resistant strains of Streptococcus pneumoniae cause lethal murine pneumonia?. [abstract no. 452]. 40th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Toronto, Canada: American Society of Microbiology, 2000
Björkman J, Hugues D, Andersson DI. Virulence of antibiotic resistant Salmonella typhimurium. Proc Natl Acad Sci U S A 1998; 95: 3949–53
Einarsson S, Kristjansson M, Kristinsson KG, et al. Pneumonia caused by penicillin-nonsusceptible and penicillin-susceptible pneumococci in adults: a case control study. Scand J Infect Dis 1998; 30: 253–6
Feikin DR, Schuchat A, Kolczac M, et al. Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995–1997. Am J Public Health 2000; 90(2): 223–9
Matlay JP, Hofmann J, Cetron MS, et al. Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia. Clin Infect Dis 2000; 30: 520–8
Negri MC, Morosini MI, Loza E, et al. In vitro selective antibiotic concentrations of beta-lactams for penicillin-resistant Streptococcus pneumoniae. Antimicrob Agents Chemother 1994; 38(1): 122–5
Cohen R, Bingen E, Varon E, et al. Change in nasopharyngeal carriage of Streptococcus pneumoniae resulting from antibiotic therapy for acute otitis media in children. Pediatr Infect Dis J 1997; 16(6): 555–60
Dagan R, Yagupsky P, Goldbart A, et al. Increasing prevalence of penicillin-resistant pneumococcal infections in children in southern Israel: Implications for future immunization policies. Pediatr Infect Dis J 1994; 13: 782–6
Hausdorff WP, Bryant J, Paradiso PR, et al. Which pneumococcal serogroup cause most invasive disease: Implications for conjugate vaccine formulation and use. Clin Infect Dis 2000; 30(Pt I): 100–21
Hausdorff WP, Bryant J, Kloek C, et al. The contribution of specific pneumococcal serogroups to different disease manifestations: Implications for conjugate vaccine formulation and use. Clin Infect Dis 2000; 30 (Pt II) 30: 122–40
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Carbon, C., Isturiz, R. Narrow Versus Broad Spectrum Antibacterials. Drugs 62, 1289–1294 (2002). https://doi.org/10.2165/00003495-200262090-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-200262090-00001